BPG is committed to discovery and dissemination of knowledge
Featured Articles
1/22/2018 1:11:31 AM | Browse: 752 | Download: 544
Publication Name World Journal of Gastroenterology
Manuscript ID 37039
Country/Territory United States
Received
2017-11-07 05:48
Peer-Review Started
2017-11-07 08:02
To Make the First Decision
2017-11-30 06:02
Return for Revision
2017-12-01 09:32
Revised
2017-12-05 19:10
Second Decision
2017-12-12 08:42
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2017-12-12 19:42
Articles in Press
2017-12-12 19:42
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2018-01-05 07:02
Publish the Manuscript Online
2018-01-19 09:46
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates
Manuscript Source Invited Manuscript
All Author List Chiranjeevi Gadiparthi, George Cholankeril, Brandon J Perumpail, Eric R Yoo, Sanjaya Kumar Satapathy, Satheesh Nair and Aijaz Ahmed
Funding Agency and Grant Number
Corresponding Author Aijaz Ahmed, MD, Associate Professor, Attending Doctor, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, 750 Welch Road, Suite 210, Palo Alto, CA 94304, United States. aijazahmed@stanford.edu
Key Words Hepatitis C virus; Direct-acting antiviral therapy; Liver transplantation; Purgatory Model for End-stage liver disease; Sustained virological response
Core Tip Optimal timing of antiviral therapy for hepatitis C virus (HCV) infection in liver transplant candidates using second generation direct-acting antivirals is debated. Available evidence lacks conviction if the viral eradication is beneficial in all HCV patients before liver transplantation. We aim to review the current literature to better delineate the appropriate timing of HCV treatment in the era of direct-acting antiviral agents.
Publish Date 2018-01-19 09:46
Citation Gadiparthi C, Cholankeril G, Perumpail BJ, Yoo ER, Satapathy SK, Nair S, Ahmed A. Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates. World J Gastroenterol 2018; 24(3): 315-322
URL http://www.wjgnet.com/1007-9327/full/v24/i3/315.htm
DOI http://dx.doi.org/10.3748/wjg.v24.i3.315
Full Article (PDF) WJG-24-315.pdf
Full Article (Word) WJG-24-315.doc
Manuscript File 37039-Review.docx
Answering Reviewers 37039-Answering reviewers.pdf
Audio Core Tip 37039-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 37039-Conflict-of-interest statement.pdf
Copyright License Agreement 37039-Copyright license agreement.PDF
Peer-review Report 37039-Peer-review(s).pdf
Scientific Misconduct Check 37039-Scientific misconduct check.pdf
Scientific Editor Work List 37039-Scientific editor work list.pdf